The France Dermatology Devices Market was valued at $135.7 Million in 2026 and projected to reach to $240.6 Million by 2031, representing a compound annual growth rate of 12.1%. France's dermatology devices market is poised for sustained growth through 2031, driven by technological advancements in laser therapy, radiofrequency, and non-invasive treatment systems.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France's dermatology devices market is valued at USD 135.7 million in 2026 and is projected to reach USD 240.6 million by 2031, representing a robust 12.1% CAGR over the forecast period.
France's well-established healthcare system and high adoption rates of innovative medical technologies create a favorable environment for dermatology device manufacturers and service providers.
Increasing consumer demand for advanced skin treatment solutions and aesthetic procedures is driving market expansion across France, supported by growing disposable incomes and lifestyle preferences.
France is positioning itself as a key dermatology devices market within Europe, leveraging its strong medical expertise, regulatory framework, and cosmetic industry prominence.
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Offers laser and radiofrequency systems for skin tightening and resurfacing, ultrasound-based systems for body contouring, and light-based systems for pigmentation and acne treatment, alongside a dermatology pharmaceutical portfolio | Broad device and drug portfolio, strong brand recognition, and combined pharma-plus-device offering |
|
|
Provides laser, light-based, radiofrequency, and ultrasound energy-based devices for hair removal, skin rejuvenation, and body contouring, along with AI-powered skin diagnostics | Comprehensive multi-technology platform, AI-assisted treatment personalization, and a large global installed base |
|
|
Offers laser, intense pulsed light, and radiofrequency-based devices for hair removal, skin resurfacing, tattoo removal, and cellulite and skin smoothing treatments | Wide-ranging energy-based technology portfolio, established brand credibility, and extensive clinical adoption across dermatology practices |
|
|
Develops radiofrequency-based minimally and non-invasive platforms for skin tightening, resurfacing, and body contouring | Versatile multi-specialty use, minimally invasive procedures with reduced downtime, and strong clinical evidence |
|
|
Offers non-invasive energy-based devices for body contouring, muscle building, skin tightening, and facial rejuvenation | Non-invasive treatment with minimal downtime, dual-action fat and muscle technology, and extensive clinical data |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SKIN REJUVENATION & ANTI-AGING (Aesthetic Therapeutic Application) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 13.7% from 2026 to 2031 |
| Largest Segment | HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES (End User) |
| Market Size Base Year (Billions) | ~USD 9.33 (2026) |
| Revenue Forecast (Billions) | ~USD 17.73 (2031) |
| Segments Covered | Type, Application, Diagnostic Application, Medical Therapeutic Application, Aesthetic Therapeutic Application, Technology, End User |
7 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GALDERMA S.A. | Switzerland | Public Company | Injectable aesthetics,Dermatological skincare (Cetaphil, ALASTIN, others),Prescription therapeutic dermatology, |
| HENRY SCHEIN | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BAUSCH HEALTH COMPANIES INC. | Canada | Public Company | Bausch + Lomb (Eye Health Devices and Pharmaceuticals),Salix (Gastroenterology and Hepatology),International (Branded Generics and Diversified Pharmaceuticals), |
| SISRAM MEDICAL LTD | Israel | Public Company | Dermatology devices and aesthetic platforms,Dental equipment, home-use devices, injectables, and cosmeceuticals, |
| LUMENIS BE LTD. | Israel | Private Company | Aesthetic laser and light-based treatment systems,Medical therapeutic laser systems used in dermatology,Light-based and RF-based aesthetic platforms, |
| INMODE LTD | Israel | Public Company | Minimally invasive RF-assisted aesthetic systems,Non-invasive aesthetic systems (hair removal, skin rejuvenation, vascular/pigmented lesions),Hands-free aesthetic systems and women's health platforms, |
| BTL GROUP OF COMPANIES | United States | Private Company | Treatment Devices,Diagnostic Devices, |
| EL.EN. S.P.A. | Italy | Public Company | Medical,Industrial, |
| ABBVIE INC. | United States | Public Company | Aesthetics and Dermatology-Adjacent Therapies (Botox Cosmetic, Juvederm, body contouring, skincare),Neurology and Pain (Botox Therapeutic, Vraylar, Duodopa, Vyalev),Immunology and Inflammatory Diseases (Skyrizi, Rinvoq and related), |
| CUTERA, INC. | United States | Private Company | Aesthetic therapeutic treatment devices,Medical therapeutic devices (e.g., AviClear acne treatment),Diagnostic and adjunct products, including third-party skincare, |
| CANDELA CORPORATION | United States | Private Company | Laser-based treatment systems,Light-based and non-invasive body contouring systems,Service, consumables, and accessories, |
| JEISYS MEDICAL INC. | South Korea | Treatment devices - laser-based,Treatment devices - light-based,Other treatment technologies (RF, ultrasound, cryotherapy), |
Galderma S.A. is a Swiss public company founded in 1981 that operates in the pharmaceutical and dermatology sector. With 7,676 employees, the company develops and markets pharmaceutical and aesthetic products globally.
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a leading distributor of healthcare products and services to dental, medical, and veterinary professionals.
Bausch Health Companies Inc. is a Canadian public company with 20,300 employees operating in the pharmaceutical and healthcare products industry. The company develops, manufactures, and markets a diverse portfolio of pharmaceutical and medical device products.
Sisram Medical Ltd. is an Israeli public company founded in 1999 with 1,043 employees. The company develops and markets minimally invasive aesthetic and surgical medical devices.
Lumenis Be Ltd. is an Israeli private company founded in 1991 with 954 employees. The company specializes in the development and manufacture of laser and light-based medical devices for aesthetic and surgical applications.
InMode Ltd. is an Israeli public company founded in 2008 with 660 employees. The company develops and markets minimally invasive aesthetic treatment platforms using radiofrequency and other energy-based technologies.
BTL Group of Companies is a United States-based private company founded in 1985 with 134 employees. The company manufactures and distributes aesthetic and medical devices for various clinical applications.
EL.EN. S.P.A. is an Italian public company founded in 1981 with 1,379 employees. The company designs, manufactures, and sells laser systems for medical, surgical, and industrial applications.
AbbVie Inc. is a United States-based public company founded in 2012 with 57,000 employees. The company is a global pharmaceutical company that discovers, develops, and markets a broad range of medicines and therapies.
Cutera, Inc. is a United States-based private company founded in 1998 with 430 employees. The company designs and manufactures laser and other light-based aesthetic systems for medical professionals.
Candela Corporation is a United States-based private company founded in 1970 with 363 employees. The company manufactures and markets laser and light-based medical aesthetic devices.
Jeisys Medical Inc. is a South Korean company founded in 2007. The company develops and manufactures aesthetic and medical devices.
France's dermatology devices market is valued at USD 135.7 million in 2026 and is expected to reach USD 240.6 million by 2031.
France's dermatology devices market is projected to grow at a compound annual growth rate (CAGR) of 12.1% from 2026 to 2031.
Key drivers include France's advanced healthcare infrastructure, rising consumer demand for aesthetic procedures, an aging population, and increasing adoption of minimally invasive technologies.
Laser systems, radiofrequency devices, and light-based therapies are among the most widely adopted dermatological devices in France.
France represents a significant segment of the European dermatology devices market, with strong regulatory standards and high healthcare spending supporting premium device adoption.
The objective of this study is to analyze key market dynamics, including drivers, opportunities, constraints, challenges, and the strategies employed by key players. We will track developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, to assess the competitive landscape of the dermatology devices market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate market size, both top-down and bottom-up approaches were used. Market breakdown and data triangulation were employed to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Bausch Health Companies Inc. (Canada) |
Sales Manager |
|
Sisram Medical Ltd (Israel) |
Product Manager |
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the dermatology devices market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Dermatology devices assist dermatologists and surgeons in diagnosing and treating skin disorders. These devices increase the accuracy of dermatologists when diagnosing a particular type of skin disorder.
MarketsandMarkets offers the following customizations for this market report.
Additional country-level analysis of the dermatology devices market
Full forecast, segment splits, and company analysis for all Dermatology Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report